To include your compound in the COVID-19 Resource Center, submit it here.

Fuzeon enfuvirtide: Phase III; under regulatory review in the U.S. and EU

Subset analysis from the pivotal open-label international TORO 1 Phase III trial showed that patients whose virus was

Read the full 188 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE